U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Burkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder

MedGen UID:
231972
•Concept ID:
C1332642
•
Neoplastic Process
Synonyms: Burkitt's-Like Lymphoma Post-Transplant Lymphoproliferative Disorder; Burkitt's-like Lymphoma PTLD; Burkitt-like Lymphoma PTLD

Definition

A Burkitt-like lymphoma that arises in a patient with a history of organ transplantation. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVBurkitt-Like Lymphoma Post-Transplant Lymphoproliferative Disorder

Professional guidelines

PubMed

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Guerra-García P, Bomken S, Ling R, Lazareva A, Gupte G, Amrolia P, Andrés M, Diez-Sebastián J, Taj MM
Pediatr Blood Cancer 2024 Aug;71(8):e31053. Epub 2024 May 16 doi: 10.1002/pbc.31053. PMID: 38757407
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL
Clin Transplant 2012 Sep-Oct;26(5):679-83. Epub 2012 Feb 10 doi: 10.1111/j.1399-0012.2011.01593.x. PMID: 22324300

Recent clinical studies

Etiology

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Guerra-García P, Bomken S, Ling R, Lazareva A, Gupte G, Amrolia P, Andrés M, Diez-Sebastián J, Taj MM
Pediatr Blood Cancer 2024 Aug;71(8):e31053. Epub 2024 May 16 doi: 10.1002/pbc.31053. PMID: 38757407
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL
Clin Transplant 2012 Sep-Oct;26(5):679-83. Epub 2012 Feb 10 doi: 10.1111/j.1399-0012.2011.01593.x. PMID: 22324300
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).
Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-Váry M, Babel N, Trappe RU, Jonas S, Hummel M, Anagnostopoulos I, Dörken B, Riess HB
Am J Transplant 2005 Dec;5(12):2901-6. doi: 10.1111/j.1600-6143.2005.01098.x. PMID: 16303003
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E
Leuk Lymphoma 2003 Sep;44(9):1541-3. doi: 10.3109/10428190309178777. PMID: 14565657
Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease.
Campe H, Jaeger G, Abou-Ajram C, Nitschko H, Griebel M, Montoya C, Klare B, Koszinowski U
Pediatr Transplant 2003 Feb;7(1):46-52. doi: 10.1034/j.1399-3046.2003.02051.x. PMID: 12581328

Diagnosis

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Guerra-García P, Bomken S, Ling R, Lazareva A, Gupte G, Amrolia P, Andrés M, Diez-Sebastián J, Taj MM
Pediatr Blood Cancer 2024 Aug;71(8):e31053. Epub 2024 May 16 doi: 10.1002/pbc.31053. PMID: 38757407
Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification.
Grygalewicz B, Woroniecka R, Rymkiewicz G, Rygier J, Malawska N, Blachnio K, Bystydzienski Z, Borysiuk A, Nowakowska B, Pienkowska-Grela B
Cancer Genet 2020 Jul;245:1-5. Epub 2020 May 18 doi: 10.1016/j.cancergen.2020.05.001. PMID: 32531723
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL
Clin Transplant 2012 Sep-Oct;26(5):679-83. Epub 2012 Feb 10 doi: 10.1111/j.1399-0012.2011.01593.x. PMID: 22324300
Follicular lymphoma transformation to dual translocated Burkitt-like lymphoma: improved disease control associated with radiation therapy.
Parker SM, Olteanu H, VanTuinen P, Lawton CA, Schultz CJ, Christians KK, Fenske TS
Int J Hematol 2009 Dec;90(5):616-622. Epub 2009 Nov 25 doi: 10.1007/s12185-009-0444-9. PMID: 19937165
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E
Leuk Lymphoma 2003 Sep;44(9):1541-3. doi: 10.3109/10428190309178777. PMID: 14565657

Therapy

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Guerra-García P, Bomken S, Ling R, Lazareva A, Gupte G, Amrolia P, Andrés M, Diez-Sebastián J, Taj MM
Pediatr Blood Cancer 2024 Aug;71(8):e31053. Epub 2024 May 16 doi: 10.1002/pbc.31053. PMID: 38757407
Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification.
Grygalewicz B, Woroniecka R, Rymkiewicz G, Rygier J, Malawska N, Blachnio K, Bystydzienski Z, Borysiuk A, Nowakowska B, Pienkowska-Grela B
Cancer Genet 2020 Jul;245:1-5. Epub 2020 May 18 doi: 10.1016/j.cancergen.2020.05.001. PMID: 32531723
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL
Clin Transplant 2012 Sep-Oct;26(5):679-83. Epub 2012 Feb 10 doi: 10.1111/j.1399-0012.2011.01593.x. PMID: 22324300
Analysis of immunoglobulin heavy and light chain variable genes in post-transplant lymphoproliferative disorders.
Capello D, Cerri M, Muti G, Lucioni M, Oreste P, Gloghini A, Berra E, Deambrogi C, Franceschetti S, Rossi D, Alabiso O, Morra E, Rambaldi A, Carbone A, Paulli M, Gaidano G
Hematol Oncol 2006 Dec;24(4):212-9. doi: 10.1002/hon.791. PMID: 16897790
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E
Leuk Lymphoma 2003 Sep;44(9):1541-3. doi: 10.3109/10428190309178777. PMID: 14565657

Prognosis

Management of paediatric monomorphic post-transplant lymphoproliferative disorders with low-intensity treatment: A multicentre international experience.
Guerra-García P, Bomken S, Ling R, Lazareva A, Gupte G, Amrolia P, Andrés M, Diez-Sebastián J, Taj MM
Pediatr Blood Cancer 2024 Aug;71(8):e31053. Epub 2024 May 16 doi: 10.1002/pbc.31053. PMID: 38757407
Genetic progression of post-transplant Burkitt-like lymphoma case with 11q-Gain/Loss and MYC amplification.
Grygalewicz B, Woroniecka R, Rymkiewicz G, Rygier J, Malawska N, Blachnio K, Bystydzienski Z, Borysiuk A, Nowakowska B, Pienkowska-Grela B
Cancer Genet 2020 Jul;245:1-5. Epub 2020 May 18 doi: 10.1016/j.cancergen.2020.05.001. PMID: 32531723
Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
Chan TS, Hwang YY, Gill H, Au WY, Leung AY, Tse E, Chim CS, Loong F, Kwong YL
Clin Transplant 2012 Sep-Oct;26(5):679-83. Epub 2012 Feb 10 doi: 10.1111/j.1399-0012.2011.01593.x. PMID: 22324300
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).
Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-Váry M, Babel N, Trappe RU, Jonas S, Hummel M, Anagnostopoulos I, Dörken B, Riess HB
Am J Transplant 2005 Dec;5(12):2901-6. doi: 10.1111/j.1600-6143.2005.01098.x. PMID: 16303003
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Xicoy B, Ribera JM, Esteve J, Brunet S, Sanz MA, Fernández-Abellán P, Feliu E
Leuk Lymphoma 2003 Sep;44(9):1541-3. doi: 10.3109/10428190309178777. PMID: 14565657

Clinical prediction guides

Effects of mTOR and calcineurin inhibitors combined therapy in Epstein-Barr virus positive and negative Burkitt lymphoma cells.
Wowro SJ, Schmitt KRL, Tong G, Berger F, Schubert S
Int Immunopharmacol 2016 Jan;30:9-17. Epub 2015 Nov 21 doi: 10.1016/j.intimp.2015.11.020. PMID: 26613512
Effect of anti-CD 20 antibody rituximab in patients with post-transplant lymphoproliferative disorder (PTLD).
Oertel SH, Verschuuren E, Reinke P, Zeidler K, Papp-Váry M, Babel N, Trappe RU, Jonas S, Hummel M, Anagnostopoulos I, Dörken B, Riess HB
Am J Transplant 2005 Dec;5(12):2901-6. doi: 10.1111/j.1600-6143.2005.01098.x. PMID: 16303003

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...